## EXE: Expand Energy Corporation - XLE: Energy

### Executive Summary

VALUE thesis: PEG 0.24 indicates fundamental undervaluation. Consistent execution (3/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($111.27)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-18 | Piper Sandler | $138 | $136 | +1% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-18 | Piper Sandler | main | Overweight |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 47.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 11.7% (+2.4%)
- Blackrock Inc.: 8.6% (+4.2%)
- Capital Research Glo: 6.7% (+161.5%)
- State Street Corpora: 5.5% (+8.3%)
- Price (T.Rowe) Assoc: 4.6% (-10.5%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.24 indicates undervaluation relative to growth. Forward P/E 12.5x attractive for 63% earnings growth. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $28.4B |
| Beta | 0.44 |
| 52W Range | $91.02 - $126.62 |
| Short Interest | 5.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.24 |
| Forward P/E | 12.5 |
| Current P/E | 20.3 |
| YoY Growth | 62.9% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from -0.3% to -1.4% (-1.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.4pp (needs >4.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 56.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.41% (CS: 45) | Neutral |
| RSI_14 | 56.3 | Neutral |
| MACD Histogram | -0.11 | Bearish |
| vs SMA20 | 1.005x | Above |
| vs SMA50 | 1.076x | Above |
| vs SMA200 | 1.115x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $119.07
- **Stop Loss:** $111.27 (6.6% risk)
- **Target:** $134.67 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 64
- **Position Value:** $7,620.48
- **Portfolio %:** 7.62%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

### Earnings

**Next:** 2026-02-24 (Est: $1.54)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.85 | $0.97 | +14.2% |
| 2025Q2 | $1.15 | $1.10 | -4.1% |
| 2025Q1 | $1.87 | $2.02 | +8.0% |
| 2024Q4 | $0.47 | $0.55 | +17.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*